Identifying Tumors That Are Not Responsive to That Drug

The indications are going to be pethiladerived humors that actually have right hirepeds. So not only we are creating a new drug, we are also identifying the tumors that aregngto be sensitive to that particular drug. It's a bit of a recision medicine kind of or itto that of being yes instead of being genetic driven. And if we have a motation and you have a drive withit, so we don't have that.